Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Germ Cell and Embryonal

Explore clinical trials studying Neoplasms, Germ Cell and Embryonal. Study availability and eligibility vary by location and protocol.

6,098 public trials 1,231 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Germ Cell and Embryonal trial results

Recruiting

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT06172478

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +70 more
Locations
  • City of Hope Duarte, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • AdventHealth Medical Group Oncology Research at Celebration Kissimmee, Florida, United States
  • University of Illinois Cancer Center Chicago, Illinois, United States
View all 85 locations
View Trial Details
Recruiting

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

NCT05636618

Conditions
Bronchial Neuroendocrine Tumor, Central Nervous System Neoplasms, Gastro-enteropancreatic neuroendocrine tumor, +17 more
Locations
  • Mayo Clinic Jacksonville, Florida, United States
  • Biogenix Molecular Miami, Florida, United States
  • The University of Chicago Chicago, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
View all 19 locations
View Trial Details
Recruiting

A Study of Mirdametinib in People With Central Nervous System Tumors

NCT07539441

Conditions
Central Nervous System Neoplasms, Central Nervous System Tumors, Glioma, +10 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors

NCT06528691

Conditions
CNS Tumor, Central Nervous System Neoplasms, Glioma, +11 more
Locations
  • St. Jude Children's Research Hospital Memphis, Tennessee, United States
  • Hospital de Câncer de Barretos Barretos, São Paulo, Brazil
  • GRAACC Hospital (Grupo de Apoio ao Adolescente e à Criança com Câncer) São Paulo, Brazil
  • Hospital Santa Marcelina São Paulo, Brazil
View Trial Details

Related conditions